<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 25: Clinically Important Drug Interactions with Aripiprazole: 
			</caption>
<tbody>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Concomitant Drug Name or Drug Class</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Clinical Rationale</content>
<br/>
<content stylecode="bold"> </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Clinical Recommendation</content>
<br/>
<content stylecode="bold"> </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">
<br/>Strong CYP3A4 Inhibitors (e.g., itraconazole, clarithromycin) or strong CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine) </td>
<td align="justify" stylecode="Rrule" valign="top">The concomitant use of aripiprazole with strong CYP 3A4 or CYP2D6 inhibitors increased the exposure of aripiprazole compared to the use of aripiprazole alone <content stylecode="italics">[see CLINICAL PHARMACOLOGY (<linkhtml href="#Section_12.3">12.3</linkhtml>)]. </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>With concomitant use of aripiprazole with a strong CYP3A4 inhibitor or CYP2D6 inhibitor, reduce the aripiprazole dosage <content stylecode="italics">[see DOSAGE AND ADMINISTRATION (<linkhtml href="#Section_2.7">2.7</linkhtml>)]. </content>
<content stylecode="bold"> </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">
<br/>Strong CYP3A4 Inducers (e.g., carbamazepine, rifampin)<content stylecode="bold"> </content>
<br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">The concomitant use of aripiprazole and carbamazepine decreased the exposure of aripiprazole compared to the use of aripiprazole alone <content stylecode="italics">[see CLINICAL PHARMACOLOGY (<linkhtml href="#Section_12.3">12.3</linkhtml>)]. </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>With concomitant use of aripiprazole with a strong CYP3A4 inducer, consider increasing the aipiprazole dosage <content stylecode="italics">
<br/>[see DOSAGE AND ADMINISTRATION (<linkhtml href="#Section_2.7">2.7</linkhtml>)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">
<br/>Antihypertensive Drugs  <br/>
</td>
<td align="justify" stylecode="Rrule" valign="top">Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>Monitor blood pressure and adjust dose accordingly <content stylecode="italics">[see WARNINGS AND PRECAUTIONS (<linkhtml href="#Section_5.8">5.8</linkhtml>)]. </content>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Rrule" valign="top">
<br/>Benzodiazepines (e.g., lorazepam) <br/> </td>
<td align="justify" stylecode="Rrule" valign="top">The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone. The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone <content stylecode="italics">[see WARNINGS AND PRECAUTIONS (<linkhtml href="#Section_5.8">5.8</linkhtml>)] </content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<br/>Monitor sedation and blood pressure. Adjust dose accordingly. <content stylecode="bold">
<br/> </content>
</td>
</tr>
</tbody>
</table>